Lower risk of subsequent fracture among hip fracture patients: Long dosing interval of antiosteoporosis medication matters

IF 2.5 Q3 ENDOCRINOLOGY & METABOLISM

Osteoporosis and Sarcopenia Pub Date : 2023-12-01 DOI:10.1016/j.afos.2023.11.007

Chen-Yu Wang , Yi-Chien Lu , F. Shau-Huai , Hung-Kuan Yen

引用次数: 0

查看原文本刊更多论文

髋部骨折患者的后续骨折风险较低：抗骨质疏松药物的给药间隔较长

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Osteoporosis and Sarcopenia Orthopedics, Sports Medicine and Rehabilitation, Endocrinology, Diabetes and Metabolism, Obstetrics, Gynecology and Women's Health, Geriatrics and Gerontology

自引率

5.00%

发文量

审稿时长

66 days